Compare Enveric Biosciences Inc (ENVB) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Exxon Mobil Corporation — how do they compare? Enveric Biosciences Inc trades at $1.43 (market cap $5.32M), while Exxon Mobil Corporation trades at $145.71 (market cap $598.99B). The key difference: Exxon Mobil Corporation is far larger — about 112592.1× Enveric Biosciences Inc's market cap, and Exxon Mobil Corporation pays a 2.85% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | XOM | |
|---|---|---|
Market Cap | $5.32M | $598.99B |
Sector | Health | Energy |
52-Week High | $17.40 | $171.52 |
52-Week Low | $1.28 | $105.83 |
Enterprise Value | $408.82K | $638.21B |
Dividend Yield | — | 2.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
ExxonMobil (XOM) trades at $145.09, up 0.4% on the day, with a bullish technical signal from moving averages despite some overbought RSI readings. The company has beaten earnings estimates for three consecutive quarters, though revenue and net income have declined from 2022 peaks. Recent news highlights Exxon's Permian Basin advantages and potential oil price spikes to $160, while the company relocated its legal headquarters to Texas for business-friendly policies.
XOM offers value with a consensus price target of $169.30 (16.7% upside) and a 40.74% analyst buy rating, supported by a strong balance sheet and dividend. Risks include declining profitability margins, volatile oil prices, and geopolitical tensions affecting energy markets. The stock's investment case hinges on execution in low-breakeven assets and capital discipline amid uncertain macro conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
